Company Profile

Monterey Innovation Acquisition Corp., formerly Monterey Bio Acquisition Corp., is a blank check company. The Company is formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. The Company intends to focus its efforts on identifying a disruptive technology company.

Employees

Sector

Investment Holding Companies

More about the company

20/11/23	Monterey Innovation Acquisition Corp.(NasdaqGM:MTRY) dropped from NASDAQ Composite Index	CI
22/08/23	Monterey Innovation Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
18/05/23	Monterey Innovation Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
17/04/23	Monterey Bio Acquisition Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	CI
16/04/23	Monterey Innovation Acquisition Corp. Auditor Raises 'Going Concern' Doubt	CI
10/03/23	Monterey Bio Acquisition to Change Name to Monterey Innovation Acquisition	MT
10/03/23	Monterey Bio Acquisition Corporation Announces Board Changes	CI
10/03/23	Monterey Bio Acquisition Corporation Appoints Murat Omur as Chief Executive Officer	CI
10/03/23	Monterey Bio Acquisition Corporation Appoints Sean McGann as Chief Financial Officer	CI
10/11/22	Monterey Bio Acquisition Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	CI
06/10/22	Monterey Innovation Acquisition Corp. announced that it expects to receive $0.7 million in funding from Northstar Bio Ventures, LLC, Chardan Monterey Investments LLC	CI
11/08/22	Monterey Bio Acquisition Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	CI
13/05/22	Monterey Bio Acquisition Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	CI

17/04/23	MONTEREY INNOVATION ACQUISITION CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ
10/03/23	MONTEREY BIO ACQUISITION CORP : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
10/11/22	MONTEREY BIO ACQUISITION CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
11/10/22	MONTEREY BIO ACQUISITION CORP : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	AQ
30/09/22	MONTEREY BIO ACQUISITION CORP : Entry into a Material Definitive Agreement, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	AQ

Manager	Title	Age	Since
Murat Omur CEO	Chief Executive Officer	48	08/03/2023
David Smith PRN	Corporate Officer/Principal	66	-
Sanjeev Satyal CEO	Chief Executive Officer	57	31/03/2021

Director	Title	Age	Since
Jonas Grossman CHM	Chairman	52	08/03/2023
Frances K. Heller BRD	Director/Board Member	59	29/09/2021
James Neal CHM	Chairman	70	29/09/2021

Date	Insider	Type	Main position	Quantity	% Market Cap.
09/03/23	Jonas Grossman	Sell	Chairman	491,250	10.0370%
09/03/23	Sandip I. Patel	Sell	Director	645,000	13.1784%
09/03/23	Sanjeev Satyal	Others	Executive/Senior Manager	75,000	1.5324%

Monterey Innovation Acquisition Corp. Share Price

Stocks

MTRY

US61240F1084

Investment Holding Companies

Latest news : Monterey Innovation Acquisition Corp.

Press Releases: Monterey Innovation Acquisition Corp.

Quotes and Performance

Managers and Directors: Monterey Innovation Acquisition Corp.

Latest insider transactions

Shell Companies

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MONTEREY INNOVATION ACQUISITION CORP.	-0.09%	-1.59%	-	-	48.3M
CHURCHILL CAPITAL CORP XI	+2.56%	+1.51%	-	-	805M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	-0.30%	0.00%	-	-	647M
CENTIEL AG	+1.30%	-5.18%	+300.77%	-74.92%	624M
CHURCHILL CAPITAL CORP XII	0.00%	+1.03%	-	-	601M
BAIN CAPITAL GSS INVESTMENT CORP.	0.00%	-0.19%	-	-	600M
CANTOR EQUITY PARTNERS IV, INC.	+0.05%	0.00%	+2.52%	-	594M
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	-0.26%	-0.35%	-	-	568M
CHURCHILL CAPITAL CORP XIII	-0.19%	+0.38%	-	-	510M
Average	+0.34%	-0.88%	+151.64%	-74.92%	618.59M
Weighted average by Cap.	+0.49%	-0.84%	+155.38%	-74.92%